Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non‐alcoholic fatty liver disease

Sex Differences in NAFLD : State of the Art and Identification of Research Gaps

(2019) Amedeo Lonardo et al.   HEPATOLOGY

Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality

(2019) Yoosoo Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study

(2018) Yoosoo Chang et al.   HEPATOLOGY

Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population

(2018) Salvatore Petta et al.   LIVER INTERNATIONAL

Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

(2018) Yejin Kim et al.   Clinical Gastroenterology and Hepatology

Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study

(2018) Yoosoo Chang et al.   GUT

Obesity and prognosis: Time to forget about metabolically healthy obesity

(2017) Xavier Garcia-Moll   EUROPEAN HEART JOURNAL

Liver fibrosis scores predict liver disease mortality in the United States population

(2017) Aynur Unalp-Arida et al.   HEPATOLOGY

Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status

(2017) Ji Hye Huh et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Obesity and Fatty Liver Are ‘Grease’ for the Machinery of Hepatic Fibrosis

(2017) Anja Bosserhoff et al.   DIGESTIVE DISEASES

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease

(2016) Yoosoo Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Metabolically Healthy Obesity and Development of Chronic Kidney Disease

(2016) Yoosoo Chang et al.   ANNALS OF INTERNAL MEDICINE

Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study

(2016) Fabio Conti et al.   DIGESTIVE AND LIVER DISEASE

Metabolically healthy obesity and NAFLD

(2016) Giovanni Targher et al.   Nature Reviews Gastroenterology & Hepatology

Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing

(2015) Mark Hamer et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

PNPLA3polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis

(2015) Long Zhang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Natural Course of Healthy Obesity Over 20 Years

(2015) Joshua A. Bell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metabolically-Healthy Obesity and Coronary Artery Calcification

(2014) Yoosoo Chang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-invasive diagnosis of advanced fibrosis and cirrhosis

(2014) Suraj Sharma   WORLD JOURNAL OF GASTROENTEROLOGY

Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis

(2013) Priya Handa et al.   HEPATOLOGY

Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses

(2013) Chan-Won Kim et al.   JOURNAL OF HEPATOLOGY

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

(2013) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods

(2012) D. Festi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

(2010) Herbert Tilg   CURRENT PHARMACEUTICAL DESIGN

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

(2010) D. Roulot et al.   GUT

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

(2010) V. W.-S. Wong et al.   GUT

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

(2010) Brent A. Neuschwander-Tetri   HEPATOLOGY

Gluteofemoral body fat as a determinant of metabolic health

(2010) K N Manolopoulos et al.   INTERNATIONAL JOURNAL OF OBESITY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Adipocytokines and the Metabolic Complications of Obesity

(2008) Neda Rasouli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY